Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03290638
Other study ID # 13-0540-F3R
Secondary ID
Status Completed
Phase N/A
First received September 6, 2017
Last updated September 17, 2017
Start date October 3, 2013
Est. completion date October 1, 2016

Study information

Verified date September 2017
Source University of Kentucky
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this randomized clinical study was to evaluate the use of dehydrated human amnion-chorion membrane as an exposed barrier for guided bone regeneration (GBR) after tooth extraction and to determine whether intentional exposure of this membrane to the oral environment compromises ridge dimensions and bone vitality for implant placement.


Description:

Forty-three patients requiring extraction of at least one tooth and delayed implant placement were randomly assigned to either an experimental or a control group. For both groups, demineralized freeze-dried bone allograft was used to graft the socket. For the control group, Type I bovine collagen was used as a membrane; for the experimental group, human amnion-chorion membrane was used. For both groups, the barrier membranes were left exposed, and no primary closure was achieved. Patients returned for implant placement after a mean healing period of 19.5 weeks, at which time a core bone biopsy specimen 2 mm in diameter was obtained for histomorphometric analyses. Clinical ridge dimensions were measured at the times of extraction and implant placement.


Recruitment information / eligibility

Status Completed
Enrollment 43
Est. completion date October 1, 2016
Est. primary completion date October 1, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 78 Years
Eligibility Inclusion Criteria: .

Patients included in the study were required:

- Not to be completely edentulous.

- To have at least 1 tooth that could not be saved and for which extraction and delayed implant placement were planned

Exclusion Criteria: Patients were excluded if they :

- Had received radiation therapy

- Were taking antiresorptive medication (i.e., bisphosphonate or denosumab)

- Had uncontrolled systemic disorders (such as uncontrolled diabetes, congestive heart failure, or acute odontogenic infections)

- Were smokers (more than 10 cigarettes per day)

- Were pregnant or breastfeeding.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Guided Bone Regeneration (GBR)
Teeth Extraction With Bone Grafting and Membrane

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Samer Faraj

Outcome

Type Measure Description Time frame Safety issue
Primary Alveolar Ridge Dimensional Changes Clinical ridge height changes were taken with a thermoplastic triad stent, and a University of North Carolina (UNC) 15 periodontal probe. Ridge width changes measurements were taken with a metal bone caliper. Alveolar ridge dimensional changes in height and width were measured at the times of extraction and at the time of implant placement. Alveolar Ridge Dimensional Changes were taken at the extraction time and at the time of implant placement. Mean = 19.5 weeks
Primary Alveolar Ridge Bone Vitality a core bone biopsy specimen 2 mm in diameter was obtained from the center of the root at the time of implant placement for histomorphometric analyses Mean= 19.5 weeks after tooth extraction and bone grafting
Secondary Ridge Healing Evaluation Pictures of the healing ridges were taken using clinical macro lens photography Two weeks form the time of the extraction
See also
  Status Clinical Trial Phase
Completed NCT03897010 - Evaluation of Silica-calcium Phosphate Composite in Socket Augmentation Phase 4
Completed NCT03037125 - The Evaluation Of Bone Width Gain Following Split Crest Technique With Or Without Platelet Rich Fibrin( PRF) N/A
Completed NCT03607006 - Ridge Augmentation Using Patient Specific PEEK Sheets vs. Autogenous Bone Shell Technique. N/A